SS Innovations Files for Nasdaq Uplisting, $50M Offering Surgical Robotics Maker SS Innovations Plans Nasdaq Uplisting and $50M Offering

Avatar photo
Initial public offering hologram, night panoramic city view of Bangkok. The financial center for multinational corporations in Asia. The concept of boosting the growth by IPO process. Double exposure.

2d illustrations and photos

SS Innovations International (OTCPK:SSII), a surgical robotics maker, has filed to uplist its shares to Nasdaq while aiming to raise $50M through a public offering.

The company did not disclose specific terms in its recent SEC filing, but it indicated a target of approximately $50M. The offering is being managed by Freedom Capital Markets as the sole bookrunner.

Currently, shares of SS Innovations are traded on the OTC Pink Sheets market under the symbol SSII.

Headquartered in the US with operations in India, SS Innovations’ flagship product is a surgical robotics system known as SSi Mantra. The company completed a merger with CardioVentures last year.

Amidst financial challenges, SS Innovations reported a net loss of $4.8M on revenue of $4.5M for the nine-month period ended Sept. 30, 2023.


The free Daily Market Overview 250k traders and investors are reading

Read Now